Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408)
12/2009
12/10/2009WO2009116883A8 Process
12/10/2009WO2009101082A9 Substituted sulfonic acid amide compounds
12/10/2009US20090306400 Convergent process for the synthesis of taxane derivatives.
12/10/2009US20090306399 reacting an N-substituted amidine compound or a salt thereof with a ketone compound, in the presence of a base; cyclization; efficiency
12/10/2009US20090306398 Methods of treating alpha adrenergic mediated conditions
12/10/2009US20090306165 Dipeptide compounds containing d-histidine
12/10/2009US20090306161 Methods of treating alpha adrenergic mediated conditions
12/10/2009US20090306125 Mitochondria-Targeted Antioxidant Prodrugs and Methods of Use
12/10/2009US20090306110 N-(2-arylethyl)benzylamines as antagonists of the 5-ht6 receptor
12/10/2009US20090306047 Heterocyclic aspartyl protease inhibitors
12/10/2009US20090306036 Methods of screening agents, conjugates or conjugate moieties for transport by a pept2 transporter
12/09/2009EP2130822A1 2,4,5-triphenyl imidazoline derivatives as inhibitors of the interaction between p53 and mdm2 proteins for use as anticancer agents
12/09/2009EP1409450B1 N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds
12/09/2009EP1020179B1 Peptide derivatives or pharmaceutically acceptable salts thereof, method for producing the same, use of said derivatives and pharmaceutical composition
12/09/2009CN101600730A Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid
12/09/2009CN101600689A Compounds and compositions as inhibitors of cannabinoid receptor 1 activity
12/09/2009CN101600686A Water-soluble prodrugs of chloramphenicol, thiamphenicol, and analogs thereof
12/09/2009CN101597262A Mono- and bicyclic azole derivatives that inhibit the interaction of ligands with rage
12/09/2009CN101596191A Method for treatment of disease using malonyl-coa decarboxylase inhibitor
12/09/2009CN100567291C Diastereoselective synthesis process with 6-bromo-4-(3-chlorophenyl)-2-methoxy-quinoline
12/09/2009CN100567277C Production of N-containing pentabasic heteroaromatic formamidine and salts thereof
12/09/2009CN100567265C Organometallic complexes and organic electroluminescence device using the same
12/09/2009CN100567254C Process for the preparation of alpha-amino acids by hydrolysis of hydantoins at high pressure and high temperature
12/08/2009US7629477 mitotic kinesins like KSP inhibitors; for treating cellular proliferative diseases; N-(3-Aminopropyl)-N [(R)-1-3-benzyl-7-chloro-4-oxo-4H-chromen-2-yl)-2-methyl-propyl]-4-methyl-benzamide
12/08/2009US7629472 Preparing a beta-hydroxy-beta-heteroaryl ester by reacting a beta-halozinc ester Reformatsky reagent with an alpha-carbonylheteroaryl compound in the presence of a cinchona alkaloid; the heteroaryl is preferably an optionally substituted 2-pyridyl group or 4-imidazolyl group; stereospecific; drugs
12/08/2009US7629375 Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods
12/08/2009CA2422342C Novel amide derivatives and medicinal use thereof
12/03/2009WO2009146146A2 Novel ionic liquids, functionalized particulates, and fluoropolymer composites
12/03/2009WO2009146024A1 Etomidate analogues with improved pharmacokinetic and pharmacodynamic properties
12/03/2009WO2009145360A1 Benzene or thiophene derivative and use thereof as vap-1 inhibitor
12/03/2009WO2009145286A1 Heterocyclic compound
12/03/2009WO2009144961A1 Substituted carbinol compound having cyclic linker
12/03/2009WO2009144395A1 Polysubstituted derivatives of 2-heteroaryl-6-phenyl-imidazo[l,2- α] pyridines, and preparation and therapeutic use thereof
12/03/2009WO2009144394A1 Polysubstituted 2-aryl-6-phenyl-imidazo[l,2- α] pyridine derivatives, and preparation and therapeutic use thereof
12/03/2009WO2009144392A1 Polysubstituted derivatives of 6-heteroaryl-imidazo[l,2- α] pyridines, and preparation and therapeutic use thereof
12/03/2009WO2009144391A1 Polysubstituted derivatives of 2-aryl-6-phenyl-imidazo[l,2- α] pyridines, and preparation and therapeutic use thereof
12/03/2009WO2009110002A4 Novel efflux pump inhibitors
12/03/2009WO2009106817A3 1 ibeta- hydroxysteroid dehydrogenase inhibitors
12/03/2009US20090299075 neutralizing a hydrochloric or phoshoric acid salt of 4-(2-methyl-1-imidazolyl)-2,2-diphenylbutanamide with NaOH to produce high-purity 4-(2-methyl-1-imidazolyl)-2,2-diphenylbutanamide; recrystallization; for a urinary incontinence remedy; muscarinic receptor antagonist
12/03/2009US20090298901 (e)-1-(4-((1r,2s,3r)-1,2,3,4-tetrahydroxybutyl)-1h-imidazol-2-yl)ethanone oxime dihydrate and methods of its use
12/03/2009US20090298899 EP receptor (for which the endogenous ligand is prostaglandin E2, PGE2); {3-[(4-Chloro-biphenyl-3-carbonyl)-amino]-phenyl}-acetic acid; glaucoma or ocular hypertension; dysmenorrhoea, preterm labour, immune disorders, inflammatory disorders
12/03/2009US20090298189 Hydrophobic Ionic Liquids
12/03/2009US20090297447 Synthesis and evaluation of 18f-labelled-alkyl-1-[(1r)-1-phenylethyl]-1h-imidazole-5-carboxylate as a tracer for the quantification of beta-11-hydroxylase enzyme in the adrenal glands
12/03/2009CA2725680A1 Heterocyclic compound
12/03/2009CA2725111A1 Substituted carbinol compound having a cyclic linker
12/03/2009CA2725110A1 Benzene or thiophene derivative and use thereof as vap-1 inhibitor
12/03/2009CA2720228A1 Etomidate analogues with improved pharmacokinetic and pharmacodynamic properties
12/03/2009CA2719127A1 Polysubstituted derivatives of 2-heteroaryl-6-phenyl-imidazo[l,2-a] pyridines, and preparation and therapeutic use thereof
12/03/2009CA2719125A1 Polysubstituted 2-aryl-6-phenyl-imidazo[l,2-a] pyridine derivatives, and preparation and therapeutic use thereof
12/03/2009CA2719118A1 Polysubstituted derivatives of 6-heteroaryl-imidazo[l,2-a]pyridines, and preparation and therapeutic use thereof
12/03/2009CA2718953A1 Polysubstituted derivatives of 2-aryl-6-phenyl-imidazo[l,2-.alpha.] pyridines, and preparation and therapeutic use thereof
12/02/2009EP2128140A1 Method for producing 2-nitroimidazole derivative
12/02/2009EP2125750A2 Cyclic urea and carbamate inhibitors of 11beta-hydroxysteroid dehydrogenase 1
12/02/2009EP1583742B1 Cb 1 receptour inverse agonists
12/02/2009EP1392683B1 Substituted 4h-chromenes and analogs as activators of caspases and inducers of apoptosis and their use as anticancer agents
12/02/2009CN101595096A Substituted carbinol compound
12/02/2009CN101591354A Functionalized ionic liquids, and methods of use thereof
12/02/2009CN101591297A Synthetic technology of p-hydroxy-phenyl-hydantoin
12/02/2009CN101591296A High-density ionic liquid and preparation method thereof
12/02/2009CN101591258A Chiral glutamate ionic liquid
12/02/2009CN100564377C Substituted 4H-chromenes and analogs as activators of caspase and inducers of apoptosis and use thereof
12/02/2009CN100564366C Derivatives of 1,3-diones having a herbicidal activity
12/01/2009US7626040 Substituted imidazole compounds as KSP inhibitors
12/01/2009US7626038 Method for manufacturing enantiomeric imidazole compounds
12/01/2009US7625935 fungicides; good yields; steps require neither solvents nor reactants that are highly flammable and explosive, carcinogenic or corrosive; 1-chloro-4-chlorophenyl-2-butanol is reacted with the imidazole in toluene and aqueous sodium hydroxide solution in the presence of a phase transfer catalyst
12/01/2009US7625934 Metalloproteinase inhibitors
12/01/2009US7625914 2(S)-Ethoxy-3-{4-[2-(3-heptyl-1-methylureido)thiazol-4-yl]phenyl}propanoic acid; dermatology, and cardiovascular diseases, immune diseases, lipid metabolism diseases; veterinary medicine
12/01/2009US7625902 improved pharmacological properties like metabolic stability, selectivity, bioavailability and activity; Liver-X-Receptors modulators; to treat increased lipid and cholesterol levels; 4-[4-(2,5-Dimethyl-phenyl)-piperazine-1-carbonyl]-1-(3-methoxy-benzenesulfonyl)-3-phenyl-imidazolidin-2-one
12/01/2009CA2389412C N-guanidinoalkylamides, their preparation, their use, and pharmaceutical preparations comprising them
12/01/2009CA2264556C Substituted n-[(aminoiminomethyl or aminomethyl)phenyl]propyl amides
11/2009
11/26/2009WO2009143033A1 Process for the preparation of an orexin receptor antagonist
11/26/2009WO2009106713A3 New class of cationic lipids for transporting active agents into cells
11/26/2009WO2009074535A3 Method for the production of disubstituted imidazolium salts
11/26/2009US20090292126 Phosphonium cations combined with any of three fluorinated sulfonated anions such as 1,1,2,2-tetrafluoroethanesulfonate, or N,N-bis(1,1,2,2-tetrafluoroethanesulfonyl)imide; useful as solvents and catalysts
11/26/2009CA2724648A1 Process for the preparation of an orexin receptor antagonist
11/25/2009EP2122739A1 Nitroxides for lithium-ion batteries
11/25/2009EP2121621A1 Lxr and fxr modulators
11/25/2009EP2120863A1 Pharmaceutical compositions based on a microemulsion
11/25/2009EP2120576A2 Aminoazoline and urea derivatives for combating animal pests
11/25/2009EP2120574A2 Phenoxymethyl imidazoline derivatives and their use as pesticides
11/25/2009EP0931060B1 Substituted n- (aminoiminomethyl or aminomethyl)phenyl propyl amides
11/25/2009CN101586186A Method for leaching chalcopyrite and corresponding leaching agent
11/25/2009CN101585813A Prepartion method of N-acetyl-L-carnosine
11/25/2009CN101585812A Preparation method of (S) type thioic imidazolone compound
11/25/2009CN101584691A Compounds effecting glucokinase
11/25/2009CN100562517C Industrial producing method for powder, particle and sheet bromine-chlorine-dimethyl hydantoin disinfectant
11/25/2009CN100562516C Beta-amyloid protein production/secretion inhibitors
11/25/2009CN100562316C Cis-imidazolines as MDM2 inhibitors
11/24/2009US7622491 Modulators of PPAR and methods of their preparation
11/24/2009US7622422 Ionic liquids, imidazolium cations; transparent monolithic solids
11/24/2009CA2385859C 2'-substituted 1,1'-biphenyl-2-carboxamides, processes for their preparation, their use as medicament, and pharmaceutical preparations comprising them
11/19/2009WO2009139076A1 Lipoprotein lipase-activating compositions comprising benzene derivates
11/19/2009US20090287025 Fluorinating agent and method for producing fluorine-containing compound using the same
11/19/2009US20090286976 One-pot synthesis of fluorinated ionic liquids
11/19/2009US20090286841 Certain chemical entities, compositions, and methods
11/19/2009US20090286839 Phytonutrient compositions from mushrooms or filamentous fungi and methods of use
11/19/2009US20090285849 Thiosemicarbazones as anti-virals and immunopotentiators
11/19/2009US20090284134 Organic compound, charge-transporting material, composition for charge-transporting material and organic electroluminescent device
11/19/2009CA2723455A1 Lipoprotein lipase-activating compositions comprising benzene derivates
11/18/2009EP2119476A2 Amide derivatives as positive allosteric modulators and methods of use thereof
1 ... 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 ... 345